Gail Boudreaux
President and CEO, Director · Elevance Health, Inc.
- 2025
- Jul 17, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Gail Boudreaux files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian C. Cornell - $20.76M in TGT purchases and sales in the last 12 months
- Melissa K. Kremer - $2.63M in TGT purchases and sales in the last 12 months
- Cara A. Sylvester - $1.26M in TGT purchases and sales in the last 12 months
- Lisa R. Roath - $966K in TGT purchases and sales in the last 12 months
- Charles Morgan Kendrick Jr. - $911K in ELV purchases and sales in the last 12 months
- Steven H. Collis - $870K in ELV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Gail Boudreaux?
Gail Boudreaux is a corporate insider, tracked as President and CEO, Director of Elevance Health, Inc. (ELV). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Gail Boudreaux last file a Form 4?
The most recent primary Form 4 on record is dated 17 July 2026, one of 4 filings going back to 2025.
Has Gail Boudreaux been buying or selling stock?
Recorded transactions: 5 open-market purchases ($3.44M) and 0 open-market sales across all tracked filings.
